The agricultural division of Bayer increased its sales in Spain by 4% during 2016

Bayer’s agricultural division (Bayer Crop Science) closed 2016 with a 4% increase in its sales in Spain, which amounted to 193 million euros, confirming the positive trend in our country of this area of business of the company, whose turnover during last year in the Iberia region was 223 million euros, 2.6% more than in 2015. Despite the decline experienced by sales of Bayer Crop Science in Portugal, which in 2016 were 30 million (-6%), this division has been experiencing improvement and growth as a whole, which respond to Bayer’s commitment to providing innovative and sustainable solutions to farmers.

During the press conference held by Bayer to announce its business figures and lines of action, the CEO of this company in the region of Iberia, Rainer Krause, said “we have full confidence in the potential of growth in the agricultural market, so we invest fundamentally in innovation to ensure a new product line that meets the current and future challenges of the sector”.

In terms of the animal health business (Animal Health) it stood at 40 million euros (-0.9%), with a slight growth of 0.5% in Spain, where it reaches 29 million, and a decrease of 4.5% in Portugal where it stands at 10 million.

The global figures of this company in the region Iberia also confirm that positive tone and that constant bet by the innovation that Krause qualifies as “transversal in all our divisions”. “The results of 2016 show Bayer’s efforts to implement the innovative capacity of our teams in all its services. With this security, we face a 2017 full of professional challenges for the company on a global scale”, added Bayer CEO in the region Iberia.

Breaking down these figures, in 2016 Bayer invoiced LifeScience as a company of € 823 million to customers in the Iberia region (Spain and Portugal), which represents a 4% growth over the previous year. Specifically, customer turnover in Spain reached 667 million euros, 2.9% more than in the previous year, while in Portugal it was 156 million, 8.6% more than in 2015.

For Bayer’s CEO in the Iberia region, this data “shows the consolidation of growth started the previous year. In addition, these figures put us once again as one of the main markets for Bayer in the world, recovering the tenth position in the company’s ranking at the end of 2016. We are optimistic about this exercise, reinforcing our commitment to innovation and Sustainability”, he said.

Bayer maintains its commitment to the Iberia region and, especially, to the Spanish market. Thus, in 2016 more than 12 million euros were invested between Spain and Portugal, 16% more than last year, of which almost 12 million went to Spain

By divisions, Pharmaceuticals turnover in the Iberia region amounted to 427 million euros (6.8% over the previous year), of which 95 million correspond to Portugal and 332 million to sales in Portugal. Spain, 17% and 4.2%, respectively, in relation to the previous year. “Figures that show how after several years especially hard for the pharmaceutical industry due to the economic situation, 2016 has been a year of recovery of the sector. A timid recovery still, although it points to some consolidation”, says Krause.

The Consumer Health segment saw sales to customers in the Iberia region of 132 million euros (111 million in Spain) in 2016, a slight decrease of 0.9% for the Iberia Region. Specifically in Spain the drop was -2.0% while in Portugal they increased by 4.9%. “Although in 2016 this market has been affected by a worse flu and cold season, as well as by an increase in competition in the area of vitamins, the division has been able to keep its business volumes in line with the previous year, achieving double-digit growth in several of its major brands”, has unleashed Krause.

Currently, Bayer generates more than 2,200 direct jobs in the Iberia region, through 12 work centers, among which deserves special mention the Felguera Plant in Asturias, which is preparing to celebrate its anniversary (75 years ), and which stands out as the sole producer of acetylsalicylic acid Bayer, the active ingredient in Aspirin®. In order to celebrate this milestone, the company has planned a series of events and events.

Science For A Better Life

Bayer is a multinational company with key competences in the field of life sciences related to health and agriculture. With its products and services, the company wants to be useful to humanity and contribute to improving the quality of life. At the same time, the Group aims to create value through innovation, growth and high profitability. Bayer adheres to the principles of sustainability and, as a civic enterprise, acts in a socially and ethically responsible manner.

In 2016, the Bayer Group, with around 115,200 employees, had a turnover of 46.8 billion euros, made investments of 2.6 billion euros and allocated 4.7 billion euros to research and development

These figures include the business with high performance polymer materials that on October 6th, 2015 went public under the name of Covestro.

Source: Bayer

YOU MIGHT ALSO LIKE:

➡️Bayer hosts an expert forum on Fruit Logistics to discuss the challenges of the fruit and vegetable sector